Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials.

Journal of pediatric surgery - 1 Jun 2007

Kunisaki Shaun M, Armant Myriam, Kao Grace S, Stevenson Kristen, Kim Haesook, Fauza Dario O

Abstract excerpt

PURPOSE: The surgical treatment of congenital anomalies using tissues engineered from amniotic fluid-derived mesenchymal cells has been validated experimentally. As a prerequisite for testing the clinical feasibility of this therapeutic concept, this study was aimed to expand human mesenchymal am...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amniocentesis
Share to Amniotic Fluid
Share to Feasibility Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fetal Blood

Share to Gestational Age

Share to Mesenchymal Stem Cells

Share to Tissue Engineering

Source

Identifiers

PMID: 17560205
DOI: 10.1016/j.jpedsurg.2007.01.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17560205-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials.PMID 17560205Read ↗

The potential of amniotic fluid stem cells for cellular therapy and tissue engineeringSemantic proximity Read ↗

Amniotic Fluid as a Rich Source of Mesenchymal Stromal Cells for Transplantation TherapySemantic proximity Read ↗

Stem cells derived from amniotic fluid: new potentials in regenerative medicineSemantic proximity Read ↗

Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applicationsSemantic proximity Read ↗

Human amniotic fluid‐derived stem cells have characteristics of multipotent stem cellsSemantic proximity Read ↗

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.Semantic proximity Read ↗

Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.Semantic proximity Read ↗

Amnion Epithelial Cell Isolation and Characterization for Clinical UseSemantic proximity Read ↗

A novel method to derive amniotic fluid stem cells for therapeutic purposesSemantic proximity Read ↗

Mesenchymal stem cells from amnion and amniotic fluid in the bovineSemantic proximity Read ↗

Isolation, Culture, and Phenotypic Characterization of Mesenchymal Stromal Cells from the Amniotic Membrane of the Human Term Placenta.Semantic proximity Read ↗

Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.